This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kimberly-Clark to Buy I-Flow for $276M

DALLAS ( TheStreet) -- Kimberly-Clark (KMB - Get Report) agreed to purchase medical-device maker I-Flow (IFLO) in a deal valued at about $276 million, a move that Kimberly-Clark said would give its health-care division a portfolio of higher-margin products.

The maker of Huggies diapers and Kleenex tissue will buy all of I-Flow's outstanding stock for $12.65 a share (or $324 million in cash), an 8% premium to I-Flow's closing price of $11.76 on Thursday. The $276 million deal value excludes acquired cash and cash equivalents.

In morning trading Friday, I-Flow shares traded up to the tender-offer price on heavy volume.

The deal is expected to close in the fourth quarter and to modestly dilute Kimberly-Clark's earnings in 2009 and 2010. But it should begin to add to the bottom line in 2011, the company said.

The move will increase Kimberly-Clark's medical-device sales by more than 50%, the company added. I-Flow's flagship product is a kind of pump that injects local anesthetic near a patient's area of surgery. The Lake Forest, Calif., company has trailing 12-month revenue of about $137 million.

Earlier in the week, Kimberly-Clark purchased Baylis Medical's pain- management business for an undisclosed amount.

--Reported by Jeanine Poggi in New York.

Follow on Twitter and become a fan on Facebook.
Copyright 2009 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
KMB $127.94 0.46%
AAPL $92.69 -0.59%
FB $119.49 1.40%
GOOG $711.11 1.40%
TSLA $214.84 1.60%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs